Keynote Presentation: Wednesday, November 18
Wilson M. Compton, M.D., M.P.E.
Wilson M. Compton, M.D., M.P.E. is Deputy Director of the National Institute on Drug Abuse (NIDA) of the National Institutes of Health in the U.S. Department of Health and Human Services. NIDA supports much of the world’s research on the health aspects of drug abuse and addiction related to preventing drug abuse, treating addiction and addressing the serious health consequences of drug abuse, including related HIV/AIDS and other health conditions. Prior to his current appointment, Dr. Compton served as the Director of NIDA’s Division of Epidemiology, Services and Prevention Research from 2002 until 2013. In this leadership role, he oversaw the scientific direction of a complex public health research program of national and international scope addressing: 1) the extent and spread of drug abuse, 2) how to prevent drug abuse, and 3) how to implement drug abuse prevention and treatment services as effectively as possible. Before joining NIDA, Dr. Compton was Associate Professor of Psychiatry and Director of the Master in Psychiatric Epidemiology Program at Washington University in Saint Louis. Dr. Compton received his undergraduate education from Amherst College and attended medical school at Washington University. During his career, Dr. Compton has achieved multiple scientific accomplishments: he was selected to serve as a member of the DSM-5 Revision Task Force; is the author of more than 130 articles and chapters including widely-cited papers drawing attention to the emerging prescription drug abuse problems in the U.S.; and is an invited speaker at multiple high-impact venues. Dr. Compton is a member of numerous professional organizations and is the recipient of multiple awards. Of note, in 2013, Dr. Compton received the Health and Human Services Secretary’s Award for Meritorious Service.
Prevention in an Era of Shifting Drug Use – Opioids, Marijuana and E-Cigarettes
Drug use patterns shift across time and location. Implementing a responsive system of prevention means balancing universal, risk-based approaches with targeted, specific responses based on shifting patterns of drug use. Recent examples include: 1) The widespread problems of prescription opioids with more recent increases in heroin use; 2) the shifting legal landscape related to marijuana, and 3) the recent emergence of e-cigarettes (and use of similar electronic drug delivery systems for other substances) among youth. Research suggests both the value of universal drug prevention in ameliorating the impact of these emerging issues and the importance of targeted, specific approaches. Both basic and public health science are essential in guiding the development of new approaches for addressing these and other issues facing communities all across the USA.
Ralph W. Hingson, Sc.D., M.P.H
Dr. Ralph Hingson is the Director of the Division of Epidemiology and Prevention Research at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Before joining NIAAA, he was Professor and Associate Dean for Research at the Boston University School of Public Health. He has authored or co-authored 170 research articles and book chapters, including studies of the effects of: (1) Raising the legal drinking age, (2) Zero tolerance laws for drivers under 21, (3) .08% legal blood alcohol limits for adult drivers, (4) comprehensive community programs to reduce alcohol problems, (5) early drinking onset on alcohol dependence, traffic crashes, unintentional injuries and physical fights after drinking, as well as 6) assessments of morbidity and mortality associated with underage drinking, drinking by U.S. college students ages 18-24, and interventions to reduce both underage and college drinking. Dr. Hingson currently serves on the World Health Organization coordinating council to implement WHO’s global strategic plan to reduce the harmful use of alcohol.
In recognition of his research contributions, the Robert Wood Johnson Foundation honored Dr. Hingson in 2001 with its Innovators Combating Substance Abuse Award. In 2002, he received the Widmark Award, the highest award bestowed by the International Council on Alcohol Drugs and Traffic Safety (ICADTS). He is a Past President of ICADTS. In 2003, Mothers Against Drunk Driving instituted the Ralph W. Hingson Research in Practice Annual Presidential Award, with Dr. Hingson honored as its first recipient. In 2008, the American Society of Addiction Medicine conferred the R. Brinkley Smithers Distinguished Scientist Award to Dr. Hingson. In 2014, he received the University of Pittsburgh Legacy Laureate Award.
New Research Since the Surgeon General’s Call to Action to Prevent and Reduce Underage Drinking
This talk will outline new research on trends in and consequences of underage drinking as well as interventions to prevent and reduce underage drinking that have emerged since the 2007 Call to Action.